Skip to main content
Erschienen in: World Journal of Surgery 9/2009

01.09.2009

Radiofrequency Ablation for the Treatment of Autonomously Functioning Thyroid Nodules

verfasst von: Jung Hwan Baek, Won-Jin Moon, Yoon Suk Kim, Jeong Hyun Lee, Ducky Lee

Erschienen in: World Journal of Surgery | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Some patients with autonomously functioning thyroid nodules (AFTN) are not suitable for surgery or radioiodine therapy. Therefore, minimally invasive alternative treatments, such as ethanol ablation or radiofrequency ablation (RFA), are necessary.

Methods

This study included nine patients (4 toxic and 5 pretoxic patients; male to female ratio = 1:8; mean age, 47 ± 17 (range, 25–71) years) who were not eligible for surgery or radioiodine therapy. All of the patients showed hot nodule with suppression of normal thyroid gland in 99mTc pertechnetate scintigraphy. RFA was performed using a 17- and 18-gauge internally cooled electrode. Nodule volume, thyroid function, scintigraphy, symptom score (visual analogue scale, 0–10 cm), cosmetic grading score (4-point scale), and complications were evaluated before treatment and at 1, 3, and 6 months follow-up.

Results

Mean volume of the index nodule was 14.98 ± 25.53 (range, 0.29–82.29) mL. After RFA it decreased at 1 month (12.01 ± 25.97 mL, p = 0.015), 3 months (7.27 ± 15.13 mL, p = 0.011), 6 months (8.27 ± 21.29 mL, p = 0.008), and the last month (7.57 ± 19.99 mL, p = 0.008). Initial mean T3, fT4, and TSH were 156.2 ± 42.1 ng/dL, 1.73 ± 0.40 ng/dL, and 0.052 ± 0.087 mU/mL, respectively. A significant improvement of mean T3, fT4, and TSH were observed at last follow-up (T3: 116.8 ± 20.7 ng/dL, p = 0.015; fT4: 1.37 ± 0.26 ng/dL, p = 0.036; TSH: 1.454 ± 1.756 mU/mL, p = 0.012). After ablation, four patients became a cold or normal scan and five remained as a hot nodule. The mean symptom and cosmetic grading score was reduced from 2.4 ± 1.7 to 0.6 ± 0.7 (p = 0.011) and from 3.1 ± 1.2 to 1.4 ± 1.0 (p = 0.017), respectively. No major complications were encountered.

Conclusions

RFA seems to be effective and safe for the treatment of AFTN.
Literatur
1.
2.
Zurück zum Zitat Burch HB, Shakir F (1998) Fitzsimmons TR et al (1998) Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975–1996. Thyroid 8:871–880PubMedCrossRef Burch HB, Shakir F (1998) Fitzsimmons TR et al (1998) Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975–1996. Thyroid 8:871–880PubMedCrossRef
3.
Zurück zum Zitat Sandrock D, Olbricht T, Emrich D et al (1993) Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh) 128:51–55 Sandrock D, Olbricht T, Emrich D et al (1993) Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh) 128:51–55
4.
Zurück zum Zitat Parle JV, Maisonneuve P, Sheppard MC et al (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861–865PubMedCrossRef Parle JV, Maisonneuve P, Sheppard MC et al (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861–865PubMedCrossRef
5.
6.
Zurück zum Zitat Biondi B, Palmieri EA, Klain M et al (2005) Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 152:1–9PubMedCrossRef Biondi B, Palmieri EA, Klain M et al (2005) Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 152:1–9PubMedCrossRef
7.
Zurück zum Zitat Gharib H, Tuttle RM, Baskin HJ et al (2005) Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 90:581–587PubMedCrossRef Gharib H, Tuttle RM, Baskin HJ et al (2005) Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 90:581–587PubMedCrossRef
8.
Zurück zum Zitat Spiezia S, Vitale G, Di Somma C et al (2003) Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter. Thyroid 13:941–947PubMedCrossRef Spiezia S, Vitale G, Di Somma C et al (2003) Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter. Thyroid 13:941–947PubMedCrossRef
9.
Zurück zum Zitat Dossing H, Bennedbaek FN, Hegedus L (2003) Ultrasound-guided interstitial laser photocoagulation of an autonomous thyroid nodule: the introduction of a novel alternative. Thyroid 13:885–888PubMedCrossRef Dossing H, Bennedbaek FN, Hegedus L (2003) Ultrasound-guided interstitial laser photocoagulation of an autonomous thyroid nodule: the introduction of a novel alternative. Thyroid 13:885–888PubMedCrossRef
10.
Zurück zum Zitat Dossing H, Bennedbaek FN, Bonnema SJ et al (2007) Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol 157:95–100PubMedCrossRef Dossing H, Bennedbaek FN, Bonnema SJ et al (2007) Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol 157:95–100PubMedCrossRef
11.
Zurück zum Zitat Gazelle GS, Goldberg SN, Solbiati L et al (2000) Tumor ablation with radio-frequency energy. Radiology 217:633–646PubMed Gazelle GS, Goldberg SN, Solbiati L et al (2000) Tumor ablation with radio-frequency energy. Radiology 217:633–646PubMed
12.
Zurück zum Zitat Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities—part II. J Vasc Interv Radiol 12:1135–1148PubMedCrossRef Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities—part II. J Vasc Interv Radiol 12:1135–1148PubMedCrossRef
13.
Zurück zum Zitat Dupuy D, Monchik J, Decrea C et al (2001) Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 130:971–977PubMedCrossRef Dupuy D, Monchik J, Decrea C et al (2001) Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 130:971–977PubMedCrossRef
14.
Zurück zum Zitat Jeong WK, Baek JH, Rhim H et al (2008) Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18:1244–1250PubMedCrossRef Jeong WK, Baek JH, Rhim H et al (2008) Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18:1244–1250PubMedCrossRef
15.
Zurück zum Zitat Deandrea M, Limone P, Basso E et al (2008) US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol 34:784–791PubMedCrossRef Deandrea M, Limone P, Basso E et al (2008) US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol 34:784–791PubMedCrossRef
16.
Zurück zum Zitat Baek JH, Jeong HJ, Kim YS et al (2008) Radiofrequency ablation for an autonomously functioning thyroid nodule. Thyroid 18:675–676PubMedCrossRef Baek JH, Jeong HJ, Kim YS et al (2008) Radiofrequency ablation for an autonomously functioning thyroid nodule. Thyroid 18:675–676PubMedCrossRef
17.
Zurück zum Zitat Dossing H, Bennedbaek FN, Hegedus L (2006) Beneficial effect of combined aspiration and interstitial laser therapy in patients with benign cystic thyroid nodules: a pilot study. Br J Radiol 79:943–947PubMedCrossRef Dossing H, Bennedbaek FN, Hegedus L (2006) Beneficial effect of combined aspiration and interstitial laser therapy in patients with benign cystic thyroid nodules: a pilot study. Br J Radiol 79:943–947PubMedCrossRef
18.
Zurück zum Zitat Sung JY, Baek JH, Kim YS et al (2008) One-step ethanol ablation of viscous cystic thyroid nodules. AJR Am J Roentgenol 191:1730–1733PubMedCrossRef Sung JY, Baek JH, Kim YS et al (2008) One-step ethanol ablation of viscous cystic thyroid nodules. AJR Am J Roentgenol 191:1730–1733PubMedCrossRef
19.
Zurück zum Zitat Pacella CM, Bizzarri G, Spiezia S et al (2004) Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology 232:272–280PubMedCrossRef Pacella CM, Bizzarri G, Spiezia S et al (2004) Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology 232:272–280PubMedCrossRef
20.
Zurück zum Zitat Papini E, Pacella CM, Verde G (1995) Percutaneous ethanol injection (PEI): what is its role in the treatment of benign thyroid nodules? Thyroid 5:147–150PubMedCrossRef Papini E, Pacella CM, Verde G (1995) Percutaneous ethanol injection (PEI): what is its role in the treatment of benign thyroid nodules? Thyroid 5:147–150PubMedCrossRef
21.
Zurück zum Zitat Pacella CM, Bizzarri G, Guglielmi R et al (2000) Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology 217:673–677PubMed Pacella CM, Bizzarri G, Guglielmi R et al (2000) Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology 217:673–677PubMed
22.
Zurück zum Zitat Kanauchi H, Mimura Y, Kaminishi M (2001) Percutaneous radio-frequency ablation of the thyroid guided by ultrasonography. Eur J Surg 167:305–307PubMedCrossRef Kanauchi H, Mimura Y, Kaminishi M (2001) Percutaneous radio-frequency ablation of the thyroid guided by ultrasonography. Eur J Surg 167:305–307PubMedCrossRef
23.
Zurück zum Zitat Kim YS, Rhim H, Tae K et al (2006) Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid 16:361–367PubMedCrossRef Kim YS, Rhim H, Tae K et al (2006) Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid 16:361–367PubMedCrossRef
24.
Zurück zum Zitat Guglielmi R, Pacella CM, Bianchini A et al (2004) Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid 14:125–131PubMedCrossRef Guglielmi R, Pacella CM, Bianchini A et al (2004) Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid 14:125–131PubMedCrossRef
25.
Zurück zum Zitat Lippi F, Ferrari C, Manetti L et al (1996) Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study Group. J Clin Endocrinol Metab 81:3261–3264PubMedCrossRef Lippi F, Ferrari C, Manetti L et al (1996) Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study Group. J Clin Endocrinol Metab 81:3261–3264PubMedCrossRef
26.
Zurück zum Zitat Monzani F, Caraccio N, Goletti O et al (1997) Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients. Clin Endocrinol (Oxf) 46:9–15CrossRef Monzani F, Caraccio N, Goletti O et al (1997) Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients. Clin Endocrinol (Oxf) 46:9–15CrossRef
Metadaten
Titel
Radiofrequency Ablation for the Treatment of Autonomously Functioning Thyroid Nodules
verfasst von
Jung Hwan Baek
Won-Jin Moon
Yoon Suk Kim
Jeong Hyun Lee
Ducky Lee
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 9/2009
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-009-0130-3

Weitere Artikel der Ausgabe 9/2009

World Journal of Surgery 9/2009 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.